Overview

CKD-828 Drug Interaction Study (S-amlodipine)

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the Pharmacokinetic drug interaction and safety of S-amlodipine between free combination of S-amlodipine and Telmisartan and S-amlodipine monotherapy.

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Collaborator:

Asan Medical Center

Treatments:

Amlodipine
Niacin
Telmisartan